A real world study comparing the medication adherence, persistence and monotherapy duration for ixekizumab versus adalimumab, etanercept, secukinumab, or ustekinumab in patients with Psoriasis
Latest Information Update: 16 Jun 2021
At a glance
- Drugs Ixekizumab (Primary) ; Adalimumab; Etanercept; Secukinumab; Ustekinumab
- Indications Psoriasis
- Focus Therapeutic Use
- 16 Jun 2021 New trial record
- 25 Apr 2021 Results presented at the American Academy of Dermatology Virtual Meeting Experience 2021